sk&f 83959 has been researched along with Depression in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| George, SR; Hasbi, A; Madras, BK; Manduca, JD; Miksys, S; Nguyen, T; Perreault, ML; Rahal, H; Tyndale, RF | 1 |
| Fang, X; Guo, L; Jia, J; Jin, GZ; Li, JQ; Zhang, A; Zhao, B; Zhen, XC; Zheng, YY | 1 |
| Chen, JG; Deng, ZF; Fang, P; Hu, ZL; Jiang, B; Wang, F; Xiao, JL; Yang, S | 1 |
3 other study(ies) available for sk&f 83959 and Depression
| Article | Year |
|---|---|
Sex difference in dopamine D1-D2 receptor complex expression and signaling affects depression- and anxiety-like behaviors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Anxiety; Behavior, Animal; beta Catenin; Brain-Derived Neurotrophic Factor; Caudate Nucleus; Chlorocebus aethiops; Depression; Female; Glycogen Synthase Kinase 3; Male; Nucleus Accumbens; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Receptor, trkB; Receptors, Dopamine D1; Receptors, Dopamine D2; Sex Characteristics; Signal Transduction | 2020 |
SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; CHO Cells; Cricetinae; Cricetulus; Depression; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Humans; Male; Mice; Mice, Inbred C57BL; Norepinephrine Plasma Membrane Transport Proteins; Serotonin Plasma Membrane Transport Proteins | 2013 |
SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Chronic Disease; Depression; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Activation; Hippocampus; Inositol 1,4,5-Trisphosphate; Male; Membrane Glycoproteins; Mice, Inbred C57BL; Protein-Tyrosine Kinases; Receptors, Dopamine D5; RNA Interference; RNA, Small Interfering; Signal Transduction; Social Behavior; Stress, Psychological; Type C Phospholipases | 2014 |